Skip to main content
Premium Trial:

Request an Annual Quote

Altana Opens Research Institute near Boston with Focus on Genomics, Proteomics

NEW YORK, June 13 - Altana Pharma, the pharmaceutical division of Altana, opened a research center in Waltham, Mass., today  that will focus on genomics and proteomics as well as bioinformatics.

 

The center, called Altana Research Institute, is part of a five-and-a-half-year collaboration between Constance, Germany-based Altana Pharma and Munich-based GPC Biotech. Work on the center, which houses about 50 scientists, began in November 2001. Altana, of Bad Homburg, Germany, will invest a total of about $120 million in the institute.

 

Research at the ARI will focus on gastroenterology, respiratory diseases, and oncology, core areas of Altana Pharma.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.